SCHEMBL3149092

SCHEMBL3149092

[CH2]COCc1ccccc1SC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
MAPT P10636 3/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 5/20 0.43
CHRM2 P08172 1/20 0.42
SLC6A2 P23975 4/20 0.35
SLC6A4 P31645 4/20 0.35
SLC6A3 Q01959 2/20 0.34
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
APOBEC3G Q9HC16 1/20 0.32
TSHR P16473 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR7 P34969 1/20 0.31
P2RX7 Q99572 1/20 0.31
KDM4E B2RXH2 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL514989 0.80 ALDH1A1 (0.46) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL514990 0.78 ALDH1A1 (0.47) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL4801748 0.77 CHRM2 (0.48) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL30688230 0.75 HPGD (0.46) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL3157124 0.74 MAOB (0.46) LMNACHRM2TSHRKMT2A
SCHEMBL515494 0.72 ALDH1A1 (0.47) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL515495 0.72 L3MBTL1 (0.47) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL6602164 0.71 CHRM2 (0.47) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL3166142 0.71 IDO1 (0.60) L3MBTL1MAPTALDH1A1LMNACHRM2
SCHEMBL16490234 0.70 L3MBTL1 (0.60) L3MBTL1MAPTALDH1A1LMNACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
EP-2061789-A2 THIADIAZOLE COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2009-05-27 EP disclosed
WO-2008032858-A2 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF NR2C2, NR4A3, NR0B2 L3MBTL1 818/4885MAPT 4375/4885ALDH1A1 1468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.